AB
Allison Bratzel Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
23%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
93.8%
Neutral
6.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $30 |
305%
upside
| 1 | -13% |
0
%
| 11 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $930 |
18%
upside
| 2 | +8.7% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $35 |
1%
upside
| 1 | – |
–
| 4 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $77 |
4%
downside
| 2 | +40% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $102 |
5%
downside
| 1 | +5.2% |
0
%
| 4 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $3 |
433%
upside
| 1 | -45% |
0
%
| 22 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $51 |
21%
upside
| 1 | +25% |
0
%
| 24 Sep ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $112 |
2%
downside
| 1 | +72% |
0
%
| 29 Jul ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $22 |
174%
upside
| 1 | -11% |
0
%
| 2 Jun ‘25 7 months ago |
|
|
|
Overweight
Assumed
| $33 |
13%
upside
| 1 | +194% |
0
%
| 21 May ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $115 |
411%
upside
| 1 | -43% |
0
%
| 17 Mar ‘25 9 months ago |
|
|
|
Overweight
Maintained
| $6 |
295%
upside
| 1 | -10% |
0
%
| 14 Mar ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $23 |
475%
upside
| 1 | +276% |
0
%
| 11 Mar ‘25 10 months ago |
|
|
|
Overweight
Initiated
| $26 |
195%
upside
| 1 | +49% |
0
%
| 18 Feb ‘25 10 months ago |
|